A second patient with developmental delay, hypotonia, aortic insufficiency, primary hyperaldosteronism, and facial dysmorphisms was recently diagnosed by clinical exome sequencing, identifying a novel de novo CACNA1D missense mutation, thus confirming the implication of CACNA1D for primary aldosteronism and HI. This evidence concerns the gene CACNA1D and primary aldosteronism.